Results 221 to 230 of about 192,376 (298)
It is time for a more nuanced discussion about pharmacy benefit managers. [PDF]
Cantrell SA.
europepmc +1 more source
Reduction and Solid Electrolyte Interphase Formation Mechanism of Prop‐1‐ene‐1,3‐Sultone
Layer‐forming additives stabilize Li‐ion cells, yet their mechanisms remain unclear. Using operando attenuated total reflection fourier‐transform infrared spectroscopy, online electrochemical mass spectrometry, electrochemical quartz crystal microbalance with dissipation monitoring, electrochemical impedance spectroscopy, and ex situ X‐ray ...
Tim Melin +3 more
wiley +1 more source
Putting the Brakes on Infrastructure? Judicial Review Challenges to HS2 and the Critique of 'Litigant Power'. [PDF]
Guy S.
europepmc +1 more source
Aims Graduating medical students consistently report being unprepared for the complexity of prescribing in clinical practice. Current clinical prescribing teaching and authentic assessment are limited due to patient safety concerns. We aimed to examine the educational utility of supervised preprescribing as a learning process and potential authentic ...
Kellie A. Charles +7 more
wiley +1 more source
The history of GM crops in Italy : After two decades of a de facto ban, the engagement of farmers and scientists has prompted the Italian government to allow field-testing of NGT/TEA plants again. [PDF]
Defez R +6 more
europepmc +1 more source
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani +4 more
wiley +1 more source
Perspectives of psychiatrists on Mental Health Care Act, 2017: An in-depth pilot survey.
Astha, Srivastava S, Sharma I.
europepmc +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source

